BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 15240431)

  • 1. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
    Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M
    Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
    Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
    Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics.
    Della Nave R; Ginestroni A; Tessa C; Salvatore E; De Grandis D; Plasmati R; Salvi F; De Michele G; Dotti MT; Piacentini S; Mascalchi M
    Neuroimage; 2008 Oct; 43(1):10-9. PubMed ID: 18672073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging.
    Boesch SM; Wolf C; Seppi K; Felber S; Wenning GK; Schocke M
    J Magn Reson Imaging; 2007 Mar; 25(3):564-9. PubMed ID: 17326083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
    Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
    Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type 1.
    Mascalchi M; Tosetti M; Plasmati R; Bianchi MC; Tessa C; Salvi F; Frontali M; Valzania F; Bartolozzi C; Tassinari CA
    Ann Neurol; 1998 Feb; 43(2):244-52. PubMed ID: 9485066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease.
    Villanueva V; Alvarez-Linera J; Gómez-Garre P; Gutiérrez J; Serratosa JM
    Epilepsia; 2006 Apr; 47(4):788-92. PubMed ID: 16650146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum.
    Mascalchi M; Brugnoli R; Guerrini L; Belli G; Nistri M; Politi LS; Gavazzi C; Lolli F; Argenti G; Villari N
    J Magn Reson Imaging; 2002 Nov; 16(5):532-7. PubMed ID: 12412029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton MR spectroscopy of the cerebellum and pons in patients with degenerative ataxia.
    Mascalchi M; Cosottini M; Lolli F; Salvi F; Tessa C; Macucci M; Tosetti M; Plasmati R; Ferlini A; Tassinari CA; Villari N
    Radiology; 2002 May; 223(2):371-8. PubMed ID: 11997539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H-MR spectroscopy: a single voxel study of the cerebellar vermis in patients with degenerative ataxias.
    Guerrini L; Belli G; Mazzoni L; Foresti S; Ginestroni A; Della Nave R; Diciotti S; Mascalchi M
    J Magn Reson Imaging; 2009 Jul; 30(1):11-7. PubMed ID: 19557841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes.
    Prakash N; Hageman N; Hua X; Toga AW; Perlman SL; Salamon N
    Neuroimage; 2009 Aug; 47 Suppl 2():T72-81. PubMed ID: 19446636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
    Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
    Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pontine and cerebellar atrophy correlate with clinical disability in SCA2.
    Ying SH; Choi SI; Perlman SL; Baloh RW; Zee DS; Toga AW
    Neurology; 2006 Feb; 66(3):424-6. PubMed ID: 16476946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
    Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
    Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
    Iranzo A; Santamaria J; Pujol J; Moreno A; Deus J; Tolosa E
    Sleep; 2002 Dec; 25(8):867-70. PubMed ID: 12489892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6.
    Wang PS; Chen HC; Wu HM; Lirng JF; Wu YT; Soong BW
    PLoS One; 2012; 7(10):e47479. PubMed ID: 23094053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton magnetic resonance spectroscopic imaging in patients with cerebellar degeneration.
    Tedeschi G; Bertolino A; Massaquoi SG; Campbell G; Patronas NJ; Bonavita S; Barnett AS; Alger JR; Hallett M
    Ann Neurol; 1996 Jan; 39(1):71-8. PubMed ID: 8572670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.